Mike Joynes, Author at J+D Forecasting

The Future of Pharmaceutical Forecasting: Harnessing the Power of Artificial Intelligence

2nd June 2023

In today's rapidly evolving pharmaceutical landscape, accurate forecasting is more crucial than ever before. Within this era of rapid technological advancement, Artificial Intelligence (AI) has emerged as a transformative force within various industries, including pharma.

J+D selected as industry partners to work with the IT University of Copenhagen

17th April 2023

The teams will work on a project to develop a new, innovative forecasting software solution using Agile scrum methodology.

What will the trends within pharmaceutical forecasting be in 2023?

30th March 2023

The field of pharmaceutical forecasting has changed significantly over the last few years. There has been a clear demand for better forecasting due to the dynamic nature of the pharmaceutical industry.

Announcing Exciting New Functionality for FC+ Forecasting Software

31st March 2023

J+D are pleased to be bringing even more value to our clients with an update to our FC+ software suite.

What is pharmaceutical forecasting

19th January 2023

An interview by News Medical with David James, CEO J+D Forecasting about pharmaceutical forecasting, J+D Forecasting solutions and their plans for the future.

Managing pipeline products more effectively with FC365

10th November 2022

Automating manual processes to solve common forecasting challenges for New Product Planning (NPP) teams.

How to Model for Loss of Exclusivity and Generic Entrants

29th March 2023

Whether a direct threat to your originator brand, or a competitor brand losing patent, either way, it is important to build the impact into your forecast structure.

Taking the right forecasting approach for rare diseases

8th December 2022

Generating accurate forecasts for rare diseases can be challenging, especially when the treatable population is in the hundreds and there is little data to get you from one number to the next.

Accelerate Your Forecasting Process with J+D’s Proprietary Software Tool: A Case Study

7th April 2022

J+D were approached by a global pharmaceutical company with a broad pipeline across rare diseases, who needed an improved forecasting approach to evaluate a new extension line in greater detail and gain valuable insight from affiliates.

What makes a good (and bad) pharmaceutical forecast model

9th November 2022

Forecasting is essential in providing clarity on decision making about the future, and good quality forecasts can prevent decisions being made which could be commercially damaging to organisations.

Tips for Forecasting First in Class Treatments

9th November 2022

The first step to creating a forecast for a first-in-class treatment is to define your model structure based on the potential source of business.

J+D release FC365 Lite

20th March 2023

For pharma clients looking to take their first steps into an integrated forecasting solution.